Vaccinia Virus
Studies from University of Maryland describe new findings in vaccinia virus
Published in Cancer Weekly, January 30th, 2007
A report, "Vaccinia virus inhibits T cell receptor-dependent responses by human gammadelta T cells," is newly published data in The Journal of Infectious Diseases. "Vaccinia virus (VV) is an effective vaccine and vector but has evolved multiple mechanisms for evading host immunity. We characterized the interactions of VV (TianTan and New York City Board of Health strains) with human gammadelta T cells because of the role they play in immune control of this virus," investigators in the United States report.
"Exposure to VV failed to trigger proliferative responses in gammadelta T cells from unprimed individuals, but it was an unexpected finding that VV blocked responses...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-01-30)
More Articles from Cancer Weekly
- Cancer Therapy
Genetic factors are associated with head and neck cancer - Colon Cancer
Nuvelo initiates trial of rNAPc2 in metastatic colorectal cancer - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Hoshi University, Institute of Medicinal Chemistry - Cancer Gene Therapy
Investigators at Hanyang University, Department of Chemical Engineering target cancer gene therapy - Cancer Gene Therapy
Kanazawa University describes research in cancer gene therapy - Cancer Gene Therapy
New cancer gene therapy study results from Sapporo Medical University, Department of Pathology described - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
